Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

D Brandsma, L Stalpers, W Taal, P Sminia… - The lancet …, 2008 - thelancet.com
Since the introduction of chemoradiotherapy with temozolomide as the new standard of care
for patients with glioblastoma, there has been an increasing awareness of progressive and …

Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving …

BM Ellingson, C Chung, WB Pope, JL Boxerman… - Journal of neuro …, 2017 - Springer
The wide variety of treatment options that exist for glioblastoma, including surgery, ionizing
radiation, anti-neoplastic chemotherapies, anti-angiogenic therapies, and active or passive …

Incorporating diffusion-and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients

JY Kim, JE Park, Y Jo, WH Shim, SJ Nam… - Neuro …, 2019 - academic.oup.com
Background Pseudoprogression is a diagnostic challenge in early posttreatment
glioblastoma. We therefore developed and validated a radiomics model using …

Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis

SB Strauss, A Meng, EJ Ebani… - Neuroimaging …, 2021 - neuroimaging.theclinics.com
Eighty percent of all malignant primary brain tumors diagnosed in the United States are
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …

Pseudoprogression and pseudoresponse in the treatment of gliomas

D Brandsma, MJ van den Bent - Current opinion in neurology, 2009 - journals.lww.com
Both pseudo-phenomenona confuse the assessment of outcome of brain tumours in clinical
practice and in clinical trials. To overcome these issues, alternative endpoints and response …

Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

C Erker, B Tamrazi, TY Poussaint, S Mueller… - The Lancet …, 2020 - thelancet.com
Response criteria for paediatric high-grade glioma vary historically and across different
cooperative groups. The Response Assessment in Neuro-Oncology working group …

[HTML][HTML] The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence

K Parvez, A Parvez, G Zadeh - International journal of molecular sciences, 2014 - mdpi.com
Radiation therapy is an important modality used in the treatment of patients with brain
metastatic disease and malignant gliomas. Post-treatment surveillance often involves serial …

Head and Neck Squamous Cell Carcinoma: Value of Diffusion-weighted MR Imaging for Nodal Staging1

V Vandecaveye, F De Keyzer, V Vander Poorten… - Radiology, 2009 - pubs.rsna.org
Purpose: To evaluate diffusion-weighted (DW) magnetic resonance (MR) imaging, as
compared with turbo spin-echo MR imaging, for the detection of nodal metastases in head …

Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response1

JM Provenzale, S Mukundan, DP Barboriak - Radiology, 2006 - pubs.rsna.org
Diffusion-weighted magnetic resonance (MR) imaging and perfusion MR imaging are
advanced techniques that provide information not available from conventional MR imaging …

Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies

N Verma, MC Cowperthwaite, MG Burnett… - Neuro …, 2013 - academic.oup.com
Differentiating treatment-induced necrosis from tumor recurrence is a central challenge in
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …